High Intensity Aerobic Interval Training Versus Continuous Training in Heart Failure Patients.

Effects of High Intensity Aerobic Interval Training Versus Continuous Training in Heart Failure Patients.

To determine the effect of high intensity aerobic interval training versus continuous aerobic training in heart failure patients.

Study Overview

• Status: Completed
• Conditions: Heart Failure
• Intervention / Treatment: Other: High Intensity interval Training; Other: Continuous Aerobic training

• Study Type: Interventional
• Enrollment (Actual): 26
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Pakistan
  • Punjab
    • Rawalpindi, Punjab, Pakistan, 44000
      • Railway General Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Patient with heart failure including both male and female
• Patients who can perform 6 MWT.
• According to classification of American heart association, class 1 heart failure patients are included.

Exclusion Criteria:

• Heart failure patients along with orthopedic problems.
• Patients who have use pacemaker.
• Patient who have recent acute myocardial infraction or revascularization less than 3 months.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: High Intensity interval Training	Other: High Intensity interval Training; High Intensity interval Training; Frequency: 3-5 day per week; Intensity: 60 to 80% of HRR. If atrial fibrillation present use RPE of 11-14 on a 6-20 scale.; Time: total 30 mint time.6 mint exercise with high intensity and 2 mints of low intensity for active recovery until 30 mints complete. Type: walking and static cycling. Walking; Frequency 3 -5 days per week Intensity : use RPE of 11-14.; Time:30 mint total. 6 mint walk with high intensity and 2 mint walk with low intensity until 30mints completed.
Active Comparator: Continuous Aerobic training	Other: Continuous Aerobic training; Continuous Aerobic training; Frequency : 3-5 days per week.; Intensity:40-70% of HHR.; Time : initial 5-10 then 10-15 until 30mints without rest interval; Type : walking and static cycling.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
6MWT Distance	Changes from the baseline, 6 min walk test was used to measure Functional capacity. It is a sub maximal exercise test which can aid in assessing functional capacity of patients with cardiopulmonary diseases, in this test we find out the maximum distance in meters which an individual covers in 6 min.	8 week
Minnesota living with heart failure questionnaire	MLWHFQ is commonly used health related quality of life questionnaires with heart failure. This is very easy to apply on patients and self-administered questionnaire. It has two components emotional and physical and total score. Each item is scored in a 6.likert scale (0 to 5), thus, the total score could range from 5 to 105, with higher scores indicating more significant impairment in health related quality of life. Changes from the basline will be measured	8 week
Pulse Rate	Changes from baseline, Pulse rate was measured per minute through pulse oximeter	8 week
Oxygen Saturation (SpO2)	Changes from baseline SPO2 was measured in percentage. Oxygen immersion is the division of oxygen-soaked hemoglobin with respect to add up to hemoglobin in the blood. Pulse oximeter measure it.	8 week
Modified Borg dyspnea scale	Changes from the Baseline, It is a subjective numeric scale ranging from 0 to 10, where 0 indicates "no dyspnea" and 10 indicates "unbearable dyspnea." A number is chosen by the patient in order to decide the best score that matches his level of dyspnea during physical activity.	8 week

Collaborators and Investigators

• Sponsor: Riphah International University
• Investigators: Principal Investigator: Muhammad Iqbal Tariq, PhD*, Riphah International University

Study record dates

Study Major Dates

• Study Start (Actual): September 1, 2023
• Primary Completion (Actual): December 15, 2023
• Study Completion (Actual): December 15, 2023

Study Registration Dates

• First Submitted: July 7, 2023
• First Submitted That Met QC Criteria: July 7, 2023
• First Posted (Actual): July 17, 2023

Study Record Updates

• Last Update Posted (Actual): March 5, 2024
• Last Update Submitted That Met QC Criteria: March 4, 2024
• Last Verified: March 1, 2024

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Heart Diseases; Cardiovascular Diseases; Heart Failure
• Other Study ID Numbers: REC/01653 Hafiza Misbah Inayat

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No